Table 2.
Patterns and distribution of recurrence in early vs. late survivors
| Early survivors n=20; N (%) |
Late survivors n=81; N (%) |
HPV-negative (N=26) | HPV-positive (N=75) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| P- value |
Early | Late | P- value |
Early | Late | P- value |
|||
| Site of recurrence: | |||||||||
| Locoregional | 9 (45) | 53 (65.4) | .093 | 4 (44.4) | 11(64.7) | .32 | 5 (45.5) | 42(65.6) | .201 |
| Distant | 11 (55) | 28 (34.6) | 5 (55.6) | 6 (35.3) | 6 (54.5) | 22(34.4) | |||
| Number of recurrent episodes: | .087* | .13 | .33* | ||||||
| Single | 14 (70) | 40 (49.4) | .23^ | 7 (77.8) | 8 (47.1) | 7 (63.6) | 32 (50) | .59^ | |
| Multiple | 5 (25) | 37 (45.7) | 2 (22.2) | 9 (52.9) | 3 (27.3) | 28(43.8) | |||
| Unknown | 1 (5) | 4 (4.9) | 0 (0) | 0(0) | 1 (9.1) | 4 (6.2) | |||
| Time to Recurrence: | <.001 | .019 | <.001 | ||||||
| < 12 months | 15 (75) | 16 (19.8) | 8 (88.9) | 7 (41.2) | 7 (63.6) | 9 (14.1) | |||
| >= 12 months | 5 (25) | 65 (80.2) | 1 (11.1) | 10(58.8) | 4 (36.4) | 55(85.9) | |||
*
statistic excluding unknowns
^
statistic including unknowns